Total Payments
$107,584
2024 Payments
$4,245
Companies
11
Transactions
99
Payment Breakdown by Category
Consulting$70,702 (65.7%)
Other$19,605 (18.2%)
Travel$15,208 (14.1%)
Food & Beverage$2,048 (1.9%)
Education$22.29 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,702 | 28 | 65.7% |
| Travel and Lodging | $15,208 | 28 | 14.1% |
| Honoraria | $12,860 | 3 | 12.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,745 | 3 | 6.3% |
| Food and Beverage | $2,048 | 35 | 1.9% |
| Education | $22.29 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $26,907 | 27 | $0 (2023) |
| SWEDISH ORPHAN BIOVITRUM AB | $22,690 | 9 | $0 (2022) |
| PFIZER INC. | $17,830 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $16,613 | 19 | $0 (2021) |
| SOBI, INC | $6,759 | 11 | $0 (2020) |
| AbbVie, Inc. | $6,362 | 15 | $0 (2018) |
| Alkermes, Inc. | $3,600 | 1 | $0 (2023) |
| Qiagen, LLC | $3,199 | 1 | $0 (2023) |
| Miach Orthopaedics, Inc. | $1,800 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $1,699 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,245 | 2 | PFIZER INC. ($3,780) |
| 2023 | $8,081 | 6 | Alkermes, Inc. ($3,600) |
| 2022 | $18,948 | 3 | SWEDISH ORPHAN BIOVITRUM AB ($13,698) |
| 2021 | $14,213 | 6 | Novartis Pharmaceuticals Corporation ($5,050) |
| 2020 | $8,178 | 6 | E.R. Squibb & Sons, L.L.C. ($5,014) |
| 2019 | $20,984 | 24 | E.R. Squibb & Sons, L.L.C. ($9,381) |
| 2018 | $8,417 | 21 | AbbVie, Inc. ($6,362) |
| 2017 | $24,519 | 31 | Swedish Orphan Biovitrum AB ($6,919) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug) | Honoraria | Cash or cash equivalent | $3,780.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| 11/12/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $47.27 | General |
| 10/02/2023 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 03/22/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $232.50 | General |
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 03/06/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $71.76 | General |
| 01/25/2023 | Qiagen, LLC | — | Consulting Fee | Cash or cash equivalent | $3,199.07 | General |
| 09/19/2022 | SWEDISH ORPHAN BIOVITRUM AB | Kineret (Drug) | Travel and Lodging | Cash or cash equivalent | $10,097.62 | General |
| Category: Immunology | ||||||
| 09/19/2022 | SWEDISH ORPHAN BIOVITRUM AB | Kineret (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Immunology | ||||||
| 04/04/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| 11/19/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Consulting Fee | Cash or cash equivalent | $757.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Consulting Fee | Cash or cash equivalent | $1,262.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2021 | Miach Orthopaedics, Inc. | BEAR Implant (Bridge-Enhanced ACL Restoration) (Device) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Orthopaedics | ||||||
| 06/23/2021 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Consulting Fee | Cash or cash equivalent | $3,030.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2021 | PFIZER INC. | XELJANZ (Drug) | Honoraria | Cash or cash equivalent | $5,000.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/18/2021 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Consulting Fee | Cash or cash equivalent | $2,362.50 | General |
| Category: Immunology | ||||||
| 11/23/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,433.00 | General |
| 10/02/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| 09/03/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| 07/28/2020 | SOBI, INC | GAMIFANT (Drug) | Education | In-kind items and services | $18.60 | General |
| Category: HEMATOLOGY | ||||||
| 07/22/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/10/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $81.20 | General |
| 12/20/2019 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $8,270.00 | General |
| 12/13/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
About Dr. Peter Nigrovic, MD
Dr. Peter Nigrovic, MD is a Rheumatology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154388528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Nigrovic, MD has received a total of $107,584 in payments from pharmaceutical and medical device companies, with $4,245 received in 2024. These payments were reported across 99 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($70,702).
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Pediatric Rheumatology
- Location Boston, MA
- Active Since 04/28/2006
- Last Updated 06/27/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1154388528
Products in Payments
- Kineret (Drug) $27,357
- ILARIS (Biological) $14,593
- XELJANZ (Drug) $8,799
- ORENCIA (Biological) $7,215
- Humira (Biological) $6,362
- KINERET (Drug) $2,073
- COSENTYX (Biological) $2,020
- BEAR Implant (Bridge-Enhanced ACL Restoration) (Device) $1,800
- GAMIFANT (Drug) $18.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Boston
Lee Simon, M.d, M.D
Rheumatology — Payments: $917,853
Rheumatology $917,853
Michael Weinblatt, Md, MD
Rheumatology — Payments: $408,548
Rheumatology $408,548
Sebastian Unizony, Md, MD
Rheumatology — Payments: $172,168
Rheumatology $172,168
Jack Bukowski, Md Phd, MD PHD
Rheumatology — Payments: $153,965
Rheumatology $153,965
Michael Brenner, Md, MD
Rheumatology — Payments: $141,423
Rheumatology $141,423
Dr. Joerg Ermann, Md, MD
Rheumatology — Payments: $131,409
Rheumatology $131,409